PAEDIATRIC CONSUMER HEALTH IN THE US

Euromonitor International

February 2019

LIST OF CONTENTS AND TABLES

Headlines

Prospects

Consumer Wariness Towards Chemicals Extends To Their Children

Emphasis on Natural Products Creates A Highly Competitive Environment

Biggest Trends of 2018 Include Sleep Aids and Probiotics

Competitive Landscape

Private Label Leads A Top-heavy Category

Abbott's Pedialyte Capitalises on Its Perception As A Hangover Remedy

Expect To See Significant Category Shifts As Leaders Adjust Their Portfolios

Category Data

Table 1 Sales of Paediatric Consumer Health by Category: Value 2013-2018

Table 2 Sales of Paediatric Consumer Health by Category: % Value Growth 2013-2018

Table 3 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2015-2018

Table 4 NBO Company Shares of Paediatric Consumer Health: % Value 2014-2018

Table 5 LBN Brand Shares of Paediatric Consumer Health: % Value 2015-2018

Table 6 Forecast Sales of Paediatric Consumer Health by Category: Value 2018-2023

Table 7 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2018-2023

Executive Summary

Players Innovate To Follow Consumers' Changing Lifestyles

Positive Growth in 2018, Although at A Slower Pace

A Fragmented Competitive Environment

the Move Towards Internet Retailing

Continued Growth for Consumer Health, Despite Maturity and Concern About Changes

Market Indicators

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018

Table 9 Life Expectancy at Birth 2013-2018

Market Data

Table 10 Sales of Consumer Health by Category: Value 2013-2018

Table 11 Sales of Consumer Health by Category: % Value Growth 2013-2018

Table 12 NBO Company Shares of Consumer Health: % Value 2014-2018

Table 13 LBN Brand Shares of Consumer Health: % Value 2015-2018

Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018

Table 15 Distribution of Consumer Health by Format: % Value 2013-2018

Table 16 Distribution of Consumer Health by Format and Category: % Value 2018

Table 17 Forecast Sales of Consumer Health by Category: Value 2018-2023

Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements (vds) Registration and Classification

Self-medication/self-care and Preventive Medicine

Switches

Summary 1 OTC: Switches

Sources

Summary 2 Research Sources

There is a split in how US parents view treating their children, as natural products see growing popularity among parents who want natural, holistic ways to treat their children, but persistent and steady growth is also seen by OTC products that parents know and trust, such as Johnson & Johnson’s Children’s Tylenol and Children’s Motrin. Increasingly a gap exists between these two types of paediatric products, with both seeing consistent and positive growth, while products that fall in the middl...

Euromonitor International's Paediatric Consumer Health in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Product coverage: Nappy (Diaper) Rash Treatments, Paediatric Analgesics, Paediatric Cough, Cold and Allergy Remedies, Paediatric Dermatologicals, Paediatric Digestive Remedies, Paediatric Vitamins and Dietary Supplements.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Paediatric Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.